Nanoparticles for Therapeutic Use and Targeted Drug Delivery Applications

References

[1] Xu T, Zhang N, Nichols HL, Shi D, Wen X: Modification of nanostructured materials for biomedical applications. Materials Science and Engineering: C. 2007, 27 (3): 579-594.

[2] Liu Y, Miyoshi H, Nakamura M: Nanomedicine for drug delivery and imaging: A promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles. International Journal of Cancer. 2007, 120 (12): 2527-2537.

[3] Park K, Lee S, Kang E, Kim K, Choi K, Kwon IC: New Generation of Multifunctional Nanoparticles for Cancer Imaging and Therapy. Advanced Functional Materials. 2009, 19 (10): 1553-1566.

[4] Gong, C., Deng, S., & Wu, Q. (2018). Preparation of nanoparticles composed of PLGA and polyethyleneimine as non-viral vectors for siRNA delivery. International Journal of Molecular Medicine, 42(5), 2945-2954

[5] Feng, S., & Huang, G. (2016). Applications of emulsion-based drug delivery systems in cancer therapy. Cancer Letters, 360(2), 175-185.

[6] Luo, Y., Wang, Q., & Wang, J. (2019). Biodegradable nano-polymeric systems for therapeutic and diagnostic applications. Nanotechnology Reviews, 8(1), 489-511

[7] Eley JG, Pujari VD, McLane J: Poly (Lactide-co-Glycolide) Nanoparticles Containing Coumarin-6 for Suppository Delivery: In Vitro Release Profile and In Vivo Tissue Distribution. 2004, 11 (4): 255-261.

[8] Yu, D. G., Yu, J. H., & Branford-White, C. (2018). Electrospraying method for nanoparticle synthesis and its applications in drug delivery. Chemical Engineering Research and Design, 136, 31-47.

[9] Pinto Reis C, Neufeld RJ, Ribeiro AJ, Veiga F: Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles. Nanomedicine: Nanotechnology, Biology and Medicine. 2006, 2 (1): 8-21.

[10] Danhier, F., Ansorena, E., Silva, J. M., Coco, R., Le Breton, A., & Préat, V. (2012). PLGA-based nanoparticles: An overview of biomedical applications. Journal of Controlled Release, 161(2), 505-522.

[11] Mura, S., Nicolas, J., & Couvreur, P. (2013). Stimuli-responsive nanocarriers for drug delivery. Nature Materials, 12(11), 991-1003.

[12] Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008). Factors affecting the clearance and biodistribution of polymeric nanoparticles. Molecular Pharmaceutics, 5(4), 505-515.

[13] Tran, T. H., Ramasamy, T., Truong, D. H., Shin, B. S., Choi, H. G., & Yong, C. S. (2019). Development of a novel nanostructured lipid carrier for the encapsulation and controlled release of an opioid receptor antagonist in the treatment of alcohol dependence. International Journal of Pharmaceutics, 562, 1-12

[14] Hua, S., Wu, S. Y., & editors. (2018). Nanoparticles for Biomedical Applications: Fundamental Concepts, Biological Interactions and Clinical Applications. Elsevier.

[15] Crucho C.I.C., Barros M.T. Polymeric nanoparticles: A study on the preparation variables and characterization methods. Mater. Sci Eng. C Mater. Biol. Appl. 2017; 80:771–784. doi: 10.1016/j.msec.2017.06.004. [DOI]

[16] Letchford K., Liggins R., Wasan K.M., Burt H. In vitro human plasma distribution of nanoparticulate paclitaxel is dependent on the physicochemical properties of poly (ethylene glycol)-block-poly(caprolactone) nanoparticles. Eur. J. Pharm. Biopharm. 2009; 71:196–206. doi: 10.1016/j.ejpb.2008.08.003.

[17] Hsu H.J., Bugno J., Lee S.R., Hong S. Dendrimer-based nanocarriers: A versatile platform for drug delivery. Wiley Interdiscip Rev. Nanomed. Nanobiotechnol. 2017; 9:1–21. doi: 10.1002/wnan.1409. [DOI]

[18] Ahmad Z., Shah A., Siddiq M., Kraatz H.-B. Polymeric micelles as drug delivery vehicles. RSC Adv. 2014; 4:17028–17038. doi: 10.1039/C3RA47370H

[19] Yang R., Mondal G., Wen D., Mahato R.I. Combination therapy of paclitaxel and cyclopamine polymer-drug conjugates to treat advanced prostate cancer. Nanomed. -Uk. 2017; 13:391–401. doi: 10.1016/j.nano.2016.07.017.

[20] Herrera Estrada L.P., Champion J.A. Protein nanoparticles for therapeutic protein delivery. Biomater. Sci. 2015; 3:787–799. doi: 10.1039/C5BM00052A

[21] Markovic Z., Trajkovic V. Biomedical potential of the reactive oxygen species generation and quenching by fullerenes (C60) Biomaterials. 2008; 29:3561–3573. doi: 10.1016/j.biomaterials.2008.05.005.

[22] Ho D., Wang C.H., Chow E.K. Nanodiamonds: The intersection of nanotechnology, drug development, and personalized medicine. Sci. Adv. 2015;1: e1500439. doi: 10.1126/sciadv.1500439.

[23] Pandey B., Shetake N., Balla M.S., Kumar A. Magnetic hyperthermia therapy: An emerging modality of cancer treatment in combination with radiotherapy. J. Radiat. Cancer Res. 2016; 7:13. doi: 10.4103/0973-0168.184606.

[24] Tian L., Lu L., Qiao Y., Ravi S., Salatan F., Melancon M.P. Stimuli-Responsive Gold Nanoparticles for Cancer Diagnosis and Therapy. J. Funct. Biomater. 2016; 7:19. doi: 10.3390/jfb7020019.

[25] Matea C.T., Mocan T., Tabaran F., Pop T., Mosteanu O., Puia C., Iancu C., Mocan L. Quantum dots in imaging, drug delivery and sensor applications. Int. J. Nanomed. 2017; 12:5421–5431. doi: 10.2147/IJN.S138624.

[26] Sercombe L., Veerati T., Moheimani F., Wu S.Y., Sood A.K., Hua S. Advances and Challenges of Liposome Assisted Drug Delivery. Front. Pharm. 2015; 6:286. doi: 10.3389/fphar.2015.00286.

[27] Daraee H., Etemadi A., Kouhi M., Alimirzalu S., Akbarzadeh A. Application of liposomes in medicine and drug delivery. Artif. Cells Nanomed. Biotechnol. 2016; 44:381–391. doi: 10.3109/21691401.2014.953633.

[28] Familtseva A., Jeremic N., Tyagi S.C. Exosomes: Cell-created drug delivery systems. Mol. Cell. Biochem. 2019; 459:1–6. doi: 10.1007/s11010-019-03545-4

[29] Wu P., Zhang B., Shi H., Qian H., Xu W. MSC-exosome: A novel cell-free therapy for cutaneous regeneration. Cytotherapy. 2018; 20:291–301. doi: 10.1016/j.jcyt.2017.11.002.

[30] Weber S., Zimmer A., Pardeike J. Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) for pulmonary application: A review of the state of the art. Eur J. Pharm. Biopharm. 2014; 86:7–22. doi: 10.1016/j.ejpb.2013.08.013.

[31] Luo Y., Teng Z., Li Y., Wang Q. Solid lipid nanoparticles for oral drug delivery: Chitosan coating improves stability, controlled delivery, mucoadhesion and cellular uptake. Carbohydr. Polym. 2015; 122:221–229. doi: 10.1016/j.carbpol.2014.12.084.

[32] Rao, K. (2014a). Systematic Study of Important Variables in Absorption Drug Loading into Specially Formulated Ion-Pairing PLGA Nanoparticles Using Doxorubicin Hydrochloride as Model Drug. IOSR Journal of Pharmacy and Biological Sciences, 9(3), 92–111. https://doi.org/10.9790/3008-093492111

[33] Judefeind, A., & De Villiers, M. M. (2009). Drug Loading into and In Vitro Release from Nanosized Drug Delivery Systems. In Springer eBooks (pp. 129–162). https://doi.org/10.1007/978-0-387-77668-2_5

[34] Sumana, M., Thirumurugan, A., Muthukumaran, P., & Anand, K. (2020). Biodegradable natural polymeric nanoparticles as carrier for drug delivery. In Engineering materials (pp. 231–246). https://doi.org/10.1007/978-3-030-36260-7_8

[35] Gagliardi, A., Giuliano, E., Venkateswararao, E., Fresta, M., Bulotta, S., Awasthi, V., & Cosco, D. (2021). Biodegradable polymeric nanoparticles for drug delivery to solid tumors. Frontiers in Pharmacology, 12. https://doi.org/10.3389/fphar.2021.601626

[36] Tripathi, S., Siddiqui, M. H., Kumar, A., & Vimal, A. (2022). Nanoparticles: a promising vehicle for the delivery of therapeutic enzymes. International Nano Letters., 13(3–4), 209–221. https://doi.org/10.1007/s40089-022-00391-z

[37] Eras, A., Castillo, D., Suárez, M., Vispo, N. S., Alberício, F., &Rodrı́Guez, H. (2022). Chemical conjugation in drug delivery systems. Frontiers in Chemistry, 10. https://doi.org/10.3389/fchem.2022.889083

[38] Sanopoulou, M., &Papadokostaki, K. G. (2017). Controlled Drug release Systems: mechanisms and kinetics. In WORLD SCIENTIFIC eBooks (pp. 1–33). https://doi.org/10.1142/9789813223974_0001

[39] Shargh, V. H., Hondermarck, H., & Liang, M. (2016). Antibody-targeted biodegradable nanoparticles for cancer therapy. Nanomedicine, 11(1), 63–79. https://doi.org/10.2217/nnm.15.186

[40] Sinhmar, G. K., Shah, N. N., Rawal, S., Chokshi, N. V., Khatri, H. N., Patel, B. M., & Patel, M. M. (2018). Surface engineered lipid nanoparticle-mediated site-specific drug delivery system for the treatment of inflammatory bowel disease. Artificial Cells, Nanomedicine, and Biotechnology, 46(sup2), 565–578. https://doi.org/10.1080/21691401.2018.1463232

[41] Wang H, Zhou Y, Sun Q, Zhou C, Hu S, Lenahan C, Xu W, Deng Y, Li G, Tao S. Update on Nanoparticle-Based Drug Delivery System for Anti-inflammatory Treatment. Front BioengBiotechnol. 2021 Feb 17;9:630352. doi: 10.3389/fbioe.2021.630352

[42] Mohanraj VJ, Chem Y: Nanoparticles-A Review. Tropical Journal of Pharmaceutical Research. 2006, 5 (1): 561-573.

[43] Panyam J, Zhou W-Z, Prabha S, Sahoo SK, Labhasetwar V: Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery. The FASEB Journal. 2002, 16 (10): 1217-1226.

[44] Sharma, G., Sharma, A. R., Lee, S., Bhattacharya, M., Nam, J., & Chakraborty, C. (2019). Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier. International Journal of Pharmaceutics, 559, 360–372. https://doi.org/10.1016/j.ijpharm.2019.01.056

[45] Thomsen, L. B., Thomsen, M. S., & Moos, T. (2015). Targeted drug delivery to the brain using magnetic nanoparticles. Therapeutic Delivery, 6(10), 1145–1155. https://doi.org/10.4155/tde.15.56

[46] Montegiove N, Calzoni E, Emiliani C, Cesaretti A. Biopolymer Nanoparticles for Nose-to-Brain Drug Delivery: A New Promising Approach for the Treatment of Neurological Diseases. J FunctBiomater. 2022;13(3):125. doi: 10.3390/jfb13030125.

@article{1705176,
      author = {Michael Adeniyi, Peculiar Lawrence},
      title = {Nanoparticles for Therapeutic Use and Targeted Drug Delivery Applications},
      journal = {Iconic Research And Engineering Journals},
      year = {2023},
      volume = {7},
      number = {5},
      pages = {318-331},
      issn = {2456-8880},
      url = {https://www.irejournals.com/formatedpaper/1705176.pdf},
      abstract = {This review offers a comprehensive analysis of biodegradable nanoparticles, emphasizing their biocompatibility, adaptability, and customizable characteristics, which render them ideal for drug delivery applications. It discusses various preparation techniques for biodegradable nanoparticles, through the polymerization of monomers and dispersion of preformed polymers, including solvent evaporation, solvent diffusion, nanoprecipitation, and electros praying methods, highlighting their utility in targeted drug delivery applications. The review also examines therapeutic nanoparticles and different classes of therapeutic nanoparticles, including polymer-based nanoparticles, non-polymeric nanoparticles and lipid-based nanoparticles, detailing their unique properties and significant role in optimizing drug delivery systems. It further explores strategies for drug incorporation into nanoparticles?encompassing encapsulation, surface adsorption, and chemical conjugation techniques?and investigates their release mechanisms and applications in targeted drug delivery.},
      keywords = {Nanotechnology, Therapeutic nanoparticles, Drug Delivery Systems, Encapsulation, Electrospray},
      month = {November},
  }